2-Hydroxycarbazole, a compound structurally related to the Ca2+-mobilizing
marine toxin 9-methyl-7-bromoeudistomin, has recently been proposed to acti
vate both type 1 and type 2 ryanodine receptors in skeletal and cardiac mus
cle, respectively. This study was undertaken to evaluate the activity of th
is compound in the sea urchin egg homogenate, a model system used to charac
terize intracellular Ca2+ mobilization mechanisms. 2-Hydroxycarbazole was f
ound to potently release Ca2+ in a concentration-dependent manner via a spe
cific mechanism displaying apparent desensitization. Use of selective inhib
itors of the Ca2+-mobilizing messengers inositol 1,4,5-trisphosphate, cycli
c adenosine diphosphate ribose, and nicotinic acid adenine dinucleotide pho
sphate, as well as desensitization of homogenates to each of these molecule
s, failed to inhibit the response to 2-hydroxycarbazole. However, the respo
nse to 2-hydroxycarbazole was competitively antagonized by caffeine. Invest
igation of the Ca2+ stores accessed by 2-hydroxycarbazole revealed Ca2+ rel
ease from a thapsigargin-insensitive pool. Finally, 2-hydroxycarbazole fail
ed to enhance [H-3]ryanodine binding, suggesting the operation of a nonryan
odine receptor mechanism. These results demonstrate that 2-hydroxycarbazole
is acting to modulate a Ca2+ release mechanism with distinct pharmacologic
al properties to those previously reported in the sea urchin egg.